Estrella Immunopharma (ESLA) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.12
-0.1
-0.09
-0.07

Details

Expected EPS
-0.07
Actual EPS
-0.0676
Surprise EPS
0
Surprise Percent
+3.43%

Description

Estrella Immunopharma (ESLA) has reported earnings of -0.0676 per share for Q3 2025.

0 Comments

Share your thoughts